Continued progress against hepatitis C infection.
Division of Gastroenterology, University of Michigan, Ann Arbor.
Hari
H
Conjeevaram
D000998:Antiviral Agents / Q000008:administration & dosage*; D002219:Carbamates; D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D007546:Isoquinolines / Q000008:administration & dosage*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D011759:Pyrrolidines; D013449:Sulfonamides / Q000008:administration & dosage*; D014633:Valine / Q000031:analogs & derivatives
D000998:Antiviral Agents; D002219:Carbamates; D007093:Imidazoles; D007546:Isoquinolines; D011759:Pyrrolidines; D013449:Sulfonamides; D014633:Valine; C549273:daclatasvir; C571889:asunaprevir